Hypertension artérielle : ce qui a changé en 2023 [Hypertension: what's new in 2023]

Details

Ressource 1Request a copy Under embargo until 31/07/2025.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_881915641D7B
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Hypertension artérielle : ce qui a changé en 2023 [Hypertension: what's new in 2023]
Journal
Revue medicale suisse
Author(s)
Wuerzner G., Ponte B., Pechere-Bertschi A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
31/01/2024
Peer-reviewed
Oui
Volume
20
Number
859
Pages
252-254
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Highlights for 2023 include the confirmation of hypertension as a cardiovascular risk factor and the standard procedure for measuring blood pressure. Transdermal oestrogens do not appear to be associated with an increased risk of hypertension unlike oestrogen given orally. The usefulness of blood pressure measured in hospital in elderly patients and the risks of intensive treatment are reviewed. A new study suggests that we are not all equal when it comes to recommended treatments. Finally, RNA interference technology has enabled the synthesis of a new antihypertensive treatment administered every 6 months that inhibits the production of hepatic angiotensinogen with a good effect on blood pressure.
Keywords
Aged, Humans, Hypertension/drug therapy, Blood Pressure, Antihypertensive Agents/therapeutic use, Hospitals, Technology
Pubmed
Create date
07/02/2024 16:58
Last modification date
08/02/2024 8:26
Usage data